1. Barrio JR, Melega WP, Grafton S, Perlmutter M, Nissenson C, Van Moffaert G, Hoffman J, Hawks T, Luxen A, Mazziotta JC, Huang SC, Phelps ME (1989) 4-[18F]-Fluoro-L-m-Tyrosine: a biochemical probe of striatal dopaminergic function. J Cereb Blood Flow Metab 7 [Suppl 1]: 193
2. Blin J, Sette S, Fiorelli M, Blethry O, Elghozi JL, Crouzel C, Baron JC (1989) 18F-Setoperone: a radioligand for serotonin-S2 receptor studies using PET in the human brain. J Cereb Blood Flow Metab 9:S113
3. Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, Bannister R, Marsden CD, Frackowiak RSJ (1990) Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann Neurol 28:547?555
4. Calne DB, Langston JW, Martin WRW, Stoessl AJ, Ruth TJ, Adam MJ, Pate BD, Schulzer M (1985) Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease. Nature 317:246?248
5. Chiueh CC, Burns RS, Kopin IJ, Kirk KL, Firnau G, Nahmias C, Chirakal R, Garnett ES (1986) 6-18F-DOPA/Positron emission tomography visualized degree of damage to brain dopamine in basal ganglia of monkeys with MPTP-induced parkinsonism. In: Markey SP, Castagnoli N, Trevor AJ, Kopin IJ (eds) MPTP: a neurotoxin producing a parkinsonian syndrome. Academic Press, Orlando, pp 327?338